AI Engines For more Details: Perplexity Kagi Labs You
Antimicrobial Effects: Carvacrol has potent antimicrobial properties, meaning it can inhibit the growth of bacteria, fungi, and other microorganisms. It has been shown to be effective against a wide range of pathogens, including antibiotic-resistant strains. Carvacrol's antimicrobial activity may have potential applications in the treatment of infections caused by bacteria such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, as well as fungi such as Candida albicans.
Antioxidant Effects: Carvacrol exhibits antioxidant activity, meaning it can neutralize harmful free radicals in the body. Free radicals are unstable molecules that can damage cells and contribute to aging and various diseases. By scavenging free radicals, carvacrol helps to protect cells from oxidative stress and reduce the risk of oxidative damage to tissues throughout the body.
Anti-inflammatory Effects: Carvacrol has been shown to possess anti-inflammatory properties, meaning it can reduce inflammation in the body. Chronic inflammation is associated with the development and progression of various diseases, including cardiovascular disease, neurodegenerative diseases, and cancer. By reducing inflammation, carvacrol may help to alleviate symptoms and slow the progression of these diseases.
Gastrointestinal Health: Carvacrol has been studied for its potential effects on gastrointestinal health. It may help to alleviate symptoms of gastrointestinal disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and gastric ulcers. Its antimicrobial and anti-inflammatory properties may contribute to its beneficial effects on digestive health.
Respiratory Health: Carvacrol has been investigated for its potential effects on respiratory health. It may help to alleviate symptoms of respiratory infections such as cough, congestion, and sore throat. Its antimicrobial properties may help to combat respiratory pathogens, while its anti-inflammatory effects may reduce inflammation in the respiratory tract.
Skin Health: Carvacrol has been used topically for its potential benefits in skincare. It may help to treat skin conditions such as acne, eczema, and fungal infections. Its antimicrobial and anti-inflammatory properties may help to combat acne-causing bacteria and reduce inflammation in the skin.
Rank | Probiotic | Impact |
---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Allergies | 0.5 | -0.5 | |
Ankylosing spondylitis | 0.8 | 0.8 | |
Antiphospholipid syndrome (APS) | 0.5 | 0.5 | |
Asthma | 0.5 | 0.5 | 0 |
Autism | 0.3 | 0.3 | |
Brain Trauma | 0.3 | -0.3 | |
Celiac Disease | 0.3 | 0.3 | |
Coagulation / Micro clot triggering bacteria | 0.5 | 0.5 | |
deep vein thrombosis | 0.5 | 0.5 | |
Functional constipation / chronic idiopathic constipation | 0.5 | 0.5 | |
gallstone disease (gsd) | 0.3 | 0.3 | |
Hidradenitis Suppurativa | 0.3 | 0.3 | |
hyperglycemia | 0.3 | 0.3 | |
hypertension (High Blood Pressure | 0.3 | 0.3 | 0 |
Inflammatory Bowel Disease | 0.5 | 0.5 | |
Liver Cirrhosis | 0.8 | 0.3 | 1.67 |
Long COVID | 0.3 | 0.3 | |
Metabolic Syndrome | 0.3 | 0.3 | 0 |
Obesity | 0.3 | 0.3 | 0 |
obsessive-compulsive disorder | 0.3 | 0.3 | |
Psoriasis | 0.5 | 0.5 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.3 | 0.3 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.5 | 0.5 | |
Stress / posttraumatic stress disorder | 0.3 | 0.3 | |
Type 1 Diabetes | 0.3 | -0.3 | |
Type 2 Diabetes | 0.3 | 0.3 | 0 |
Ulcerative colitis | 0.3 | 0.3 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.